Old Web
English
Sign In
Acemap
>
Paper
>
Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP for treatment of NSCLC and CRC
Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP for treatment of NSCLC and CRC
2016
Catherine Higgins
Joanna Majkut
Luke Humphreys
Jennifer Fox
M. Espona-Fiedler
Adnan Malik
Zsuzsanna Nemeth
Peter Blurton
Ray J. Boffey
Trevor Robert Perrior
David Haigh
Timothy Harrison
Daniel B. Longley
Keywords:
Immunology
Small molecule
Flip
Medicine
Cancer research
Pathology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]